30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Oyster Point Pharma Inc (OYST)

Track

Stock chart
Ticker: OYST Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
LINK WILLIAM J PHD
4 sales — total 8,160,736 USD
Planned sale 18 Oct 2021
Value US$574,336.63 | Price 69.95 | Shares 19,835
Planned sale 18 Oct 2021
Value US$3,186,839.75 | Price 425.19 | Shares 4,135
Planned sale 18 Oct 2021
Value US$3,666,957.35 | Price 15.09 | Shares 242,943
Planned sale 18 Oct 2021
Value US$4,442,692.58 | Price 14.63 | Shares 303,614
Planned sale 18 Oct 2021
Value US$275,441.13 | Price 275.87 | Shares 92,524
Planned sale 18 Oct 2021
Value US$1,426,996.01 | Price 464.60 | Shares 63,362
Planned sale 18 Oct 2021
Value US$27,977.72 | Price 14.63 | Shares 1,912
Planned sale 18 Oct 2021
Value US$4,442,692.58 | Price 14.63 | Shares 303,614
Planned sale 18 Oct 2021
Value US$23,108.76 | Price 15.09 | Shares 1,531
Planned sale 18 Oct 2021
Value US$3,666,957.35 | Price 15.09 | Shares 242,943
Planned sale 18 Oct 2021
Value US$27,977.72 | Price 14.63 | Shares 1,912
Planned sale 18 Oct 2021
Value US$4,442,692.58 | Price 14.63 | Shares 303,614
Buy 10 Aug 2020
Value US$103,880.00 | Price 25.97 | Shares 4,000
Buy 19 May 2020
Value US$3,343,004.00 | Price 28.00 | Shares 119,393
Buy 19 May 2020
Value US$1,656,984.00 | Price 28.00 | Shares 59,178
Buy 4 Nov 2019
Value US$8,022,000.00 | Price 16.00 | Shares 501,375
Buy 4 Nov 2019
Value US$3,978,000.00 | Price 16.00 | Shares 248,625
Buy 4 Nov 2019
Value US$100,800.00 | Price 16.00 | Shares 6,300
Buy 4 Nov 2019
Value US$48,000.00 | Price 16.00 | Shares 3,000
Buy 4 Nov 2019
Value US$16,000.00 | Price 16.00 | Shares 1,000
Buy 4 Nov 2019
Value US$7,000,000.00 | Price 16.00 | Shares 437,500
Buy 4 Nov 2019
Value US$2,000,000.00 | Price 16.00 | Shares 125,000
Buy 4 Nov 2019
Value US$440,000.00 | Price 16.00 | Shares 27,500
Buy 4 Nov 2019
Value US$2,480,000.00 | Price 16.00 | Shares 155,000
Buy 4 Nov 2019
Value US$2,960,000.00 | Price 16.00 | Shares 185,000
Buy 4 Nov 2019
Value US$2,480,000.00 | Price 16.00 | Shares 155,000
Buy 4 Nov 2019
Value US$14,960,000.00 | Price 16.00 | Shares 935,000
Buy 4 Nov 2019
Value US$7,000,000.00 | Price 16.00 | Shares 437,500
Buy 4 Nov 2019
Value US$2,000,000.00 | Price 16.00 | Shares 125,000
Buy 4 Nov 2019
Value US$440,000.00 | Price 16.00 | Shares 27,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-10-20 2021-10-18 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
19,835 -16.9%
69.95
US$574,337 		19,835 -16.9% 69.95 US$574,337
2021-10-20 2021-10-18 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
4,135 +47.1%
425.19
US$3,186,840 		4,135 +47.1% 425.19 US$3,186,840
2021-10-20 2021-10-18 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
77,038 -5.9%
20.25
US$337,791 		77,038 -5.9% 20.25 US$337,791
2021-10-20 2021-10-18 PlS Planned sale
1.5
LINK WILLIAM J PHD
Non-Executive Director
303,614 -22.3%
14.63
US$4,442,693 		303,614 -22.3% 14.63 US$4,442,693
2021-10-20 2021-10-18 PlS Planned sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
1,531 -23.5%
15.09
US$23,109 		1,531 -23.5% 15.09 US$23,109
2021-10-20 2021-10-18 PlS Planned sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
242,943 -23.0%
15.09
US$3,666,957 		242,943 -23.0% 15.09 US$3,666,957
2021-10-20 2021-10-18 PlS Planned sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
1,912 -22.7%
14.63
US$27,978 		1,912 -22.7% 14.63 US$27,978
2021-10-20 2021-10-18 PlS Planned sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
303,614 -22.3%
14.63
US$4,442,693 		303,614 -22.3% 14.63 US$4,442,693
2021-10-20 2021-10-18 PlS Planned sale
Ozawa Clare
Non-Executive Director Large shareholder
1,531 -23.5%
15.09
US$23,109 		1,531 -23.5% 15.09 US$23,109
2021-10-20 2021-10-18 PlS Planned sale
Ozawa Clare
Non-Executive Director Large shareholder
242,943 -23.0%
15.09
US$3,666,957 		242,943 -23.0% 15.09 US$3,666,957
2021-10-20 2021-10-18 PlS Planned sale
Ozawa Clare
Non-Executive Director Large shareholder
1,912 -22.7%
14.63
US$27,978 		1,912 -22.7% 14.63 US$27,978
2021-10-20 2021-10-18 PlS Planned sale
Ozawa Clare
Non-Executive Director Large shareholder
303,614 -22.3%
14.63
US$4,442,693 		303,614 -22.3% 14.63 US$4,442,693
2020-08-11 2020-08-10 B Purchase
0.7
Snisarenko John

Chief Commercial Officer

Officer
4,000 +133.3%
25.97
US$103,880 		4,000 +133.3% 25.97 US$103,880
2020-05-21 2020-05-19 B Purchase
1.6
InvOpps GP IV, L.L.C.
Non-Executive Director Large shareholder
119,393 +6.9%
28.00
US$3,343,004 		119,393 +6.9% 28.00 US$3,343,004
2020-05-21 2020-05-19 B Purchase
1.6
InvOpps GP IV, L.L.C.
Non-Executive Director Large shareholder
59,178 +6.9%
28.00
US$1,656,984 		59,178 +6.9% 28.00 US$1,656,984
2019-11-06 2019-11-04 B Purchase InvOpps GP IV, L.L.C. Non-Executive Director Large shareholder
501,375 +40.8%
16.00
US$8,022,000 		501,375 +40.8% 16.00 US$8,022,000
2019-11-06 2019-11-04 B Purchase InvOpps GP IV, L.L.C. Non-Executive Director Large shareholder
248,625 +40.8%
16.00
US$3,978,000 		248,625 +40.8% 16.00 US$3,978,000
2019-11-05 2019-11-04 B Purchase
3.3
Lochner Daniel

Chief Financial Officer
6,300 +inf%
16.00
US$100,800 		6,300 +inf% 16.00 US$100,800
2019-11-05 2019-11-04 B Purchase
0.7
Snisarenko John

Chief Commercial Officer
3,000 +inf%
16.00
US$48,000 		3,000 +inf% 16.00 US$48,000
2019-11-05 2019-11-04 B Purchase
Nau Jeffrey

President and CEO

Executive Director
1,000 +inf%
16.00
US$16,000 		1,000 +inf% 16.00 US$16,000
2019-11-04 2019-11-04 B Purchase Ozawa Clare Non-Executive Director
437,500 +77.3%
16.00
US$7,000,000 		437,500 +77.3% 16.00 US$7,000,000
2019-11-04 2019-11-04 B Purchase Ozawa Clare Non-Executive Director
125,000 +5.1%
16.00
US$2,000,000 		125,000 +5.1% 16.00 US$2,000,000
2019-11-04 2019-11-04 B Purchase LINK WILLIAM J PHD Non-Executive Director Large shareholder
27,500 +1.4%
16.00
US$440,000 		27,500 +1.4% 16.00 US$440,000
2019-11-04 2019-11-04 B Purchase KKR Fund Holdings L.P.
155,000 +17.5%
16.00
US$2,480,000 		155,000 +17.5% 16.00 US$2,480,000
2019-11-04 2019-11-04 B Purchase Vida Ventures, LLC Large shareholder
185,000 +23.8%
16.00
US$2,960,000 		185,000 +23.8% 16.00 US$2,960,000
2019-11-04 2019-11-04 B Purchase Falcon Vision LLC
155,000 +17.5%
16.00
US$2,480,000 		155,000 +17.5% 16.00 US$2,480,000
2019-11-04 2019-11-04 B Purchase New Enterprise Associates 14, L.P. Large shareholder
935,000 +18.7%
16.00
US$14,960,000 		935,000 +18.7% 16.00 US$14,960,000
2019-11-04 2019-11-04 B Purchase Versant Venture Capital VI, L.P. Large shareholder
437,500 +77.3%
16.00
US$7,000,000 		437,500 +77.3% 16.00 US$7,000,000
2019-11-04 2019-11-04 B Purchase Versant Venture Capital VI, L.P. Large shareholder
125,000 +5.1%
16.00
US$2,000,000 		125,000 +5.1% 16.00 US$2,000,000
2019-11-04 2019-11-04 B Purchase Versant Venture Capital VI, L.P. Large shareholder
27,500 +1.4%
16.00
US$440,000 		27,500 +1.4% 16.00 US$440,000
Explore more

More insider trading research around Oyster Point Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America